Cash & equivalents increased 553.8%
Cash & equivalents changed +553.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +553.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Debt changed +697.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +13.3% from the comparable as-filed period.
Net income changed +178.9% from the comparable as-filed period.
Operating income changed +21.1% from the comparable as-filed period.
Selling, general & administrative changed +27.3% from the comparable as-filed period.
Stock-based compensation changed +31.2% from the comparable as-filed period.
Gross margin changed +121 basis points from the comparable as-filed period.
Inventory changed +14.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -5.2% from the comparable as-filed period.
Revenue changed +10.3% from the comparable as-filed period.
Operating margin changed +61 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.